NAME OF COMPANY | CMP 18-04-2022 | Allocation | UNREALISED GAIN | |
---|---|---|---|---|
AVG INVST PRICE | ||||
SATIA IND | 95.89 | 146.95 | 43.4% | 53.2% |
TIME TECHNOPLAST | 37.99 | 88.00 | 18.7% | 131.6% |
VIPUL ORGANICS | 114.11 | 193.40 | 14.8% | 69.5% |
KG PETROCHEM | 183.57 | 324.55 | 9.8% | 76.8% |
DHP INDIA | 426.79 | 878.95 | 13.4% | 105.9% |
Dear sir,
Is satia industry @ 145 is still a good add now?
Any other from these which are still good at CMP ?.
Are you pyramiding any of these on rise?
Can you provides links/docs for vipul organics apart from annual reportsā¦
As per me all my 5 stocks have lot of runway to go,
as long as current management is in charge, Satia will keep growing for long long time, Itās cyclical business & I expect it to make higher highs with each cycle.
You can read credit rating reports, youtube videos, AGM, company website etc,
I also read Sudarshan Chemical AR & credit rating reports, concall transcripts etc
Nath Industries
Paper & chemical manufacturer spending on power approx 13-14% of sales every year, now going for In-house power generation by doing capex of 19 cr.
which may result in bringing down power(electricity) expenses.
That could increase OPM by may be 4-6% which is huge.
(9-11% OPM at present may go to 15-16%)
These are not true projections, need to find out exact savings that will come from new in house power plant.
Need to deep dive
Disc: No invested
Appreciate your research. Did you got a chance to check top line triggers and industry tailwinds wrt chemicals
Sir, I appreciate this pick, as I always wanted to find microcap stock research. Iām amateur in this. Can you please do one full detailed YouTube video, how itās done .?
How you have done sir.
Thanx.
I have not done detailed research on Nath Ind., they are focusing on both Paper & Chemical Business at the same time, which I donāt like, not yet completely rejected the idea but its on hold at the moment.
Iām also looking at other businesses for e.g. Sudarshan chemicals, NGL fine chem etc which is trading at under valuation due to pressure on input costs.
Rejected NGL Fine chem for below reasons -
- Asset turns are good at 2 to 2.5 which is illusion due to outsourcing, real asset turns may be 1.5 which makes this business capital intensive to grow.
- 100cr greenfield expansion is gone to become 140cr, that too will increase capacity by only 50%. will increase revenue by 150cr, which is asset turns of only 1.07.
- Margins are volatile.
- Other good businesses available at this point of time at even better valuations.